In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...

Novo Nordisk (NVO) and Eli Lilly (LLY) manufacture the top three weight loss drugs on the market, but heightened demand is ...

Glucagon-like peptide-1 (GLP-1) drugs can help you lose weight and manage type 2 diabetes. Whether you buy these medications online or in person, it is important to get a prescription from ...

A Lancet study suggests that popular weight-loss drugs could lead to muscle loss. Researchers recommend combining these ...

Viking Therapeutics’ GLP-1 pill candidate for treating obesity showed promise ... Viking noted there was no plateau in weight loss during the course of the 13 weeks. Among the patients in VENTURE, 88% ...

AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...

Newly published research is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people’s addiction to both opioids and alcohol. GLP-1 drugs have been a valuable treatment ...

Some 12% — or about 1 in 8 — people living in the U.S. have tried a GLP-1 drug, according to a ... don't have an appetite would be smart." Of course, as Valente noted, you can also replicate ...

It found that over 12 months, 1.4% of adolescents on GLP-1 drugs had a suicide attempt or ideation, compared with 2.3% who weren’t on the medicines. There was no sign of an increase associated ...

which releases over the course of 12 hours, to mitigate this issue. The protein, he said, is digested over a longer period of time "which translates to more protein for longer with reduced stomach ...

Increases in prescriptions for both glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter 2 (SGLT2) inhibitors were observed in patients with type 1 diabetes (T1D ...

Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage list, the agency has done the same for Novo Nordisk’s rival GLP-1 semaglutide, potentially signaling the end of a d | ...